文献速递临床试验与 GCP流行病学与生物统计组学、生物样本库与精准医学

益生元对急性营养不良幼儿微生物多样性与丰度的影响:多中心双盲随机对照试验研究方案

Effects of prebiotics on microbial diversity and abundance in young children with acute malnutrition: study protocol for a multi-centered, double-blinded randomized controlled trial.
PubMed 文献 · Trials · 2024-11-26

本研究为前瞻性、双盲、三臂、多中心随机对照试验,拟纳入6-59月龄无并发症严重急性营养不良(SAM)儿童,实验组接受即食治疗食品(RUTF)加益生元,阳性对照组接受RUTF加淀粉,疗程2个月(8周);年龄性别匹配的健康儿童进入安慰剂对照组接受淀粉。每臂58例,按1:1:1分配,主要结局为肠道微生物组多样性,次要结局包括体重别身高/身长Z评分、上臂围、神经发育评估和体质量积累。

要点

  • 6-59月龄无并发症SAM儿童随机接受RUTF加益生元、RUTF加淀粉或淀粉安慰剂,每臂58例。
  • 主要结局为肠道微生物组多样性,次要结局包括体重别身高/身长Z评分、上臂围、神经发育和体质量积累。
  • 数据收集与评估在基线和试验结束时(第8周)进行,安全性监测每两周进行,分析遵循意向性治疗原则。

核心结论

  • 作者认为本试验结果将为RUTF加益生元治疗和管理SAM儿童提供有用见解和高质量数据,并为设计大规模研究提供医学证据。

研究设计与样本

  • 前瞻性、双盲、三臂、多中心随机对照试验,6-59月龄无并发症SAM儿童按1:1:1随机分配至RUTF加益生元组、RUTF加淀粉组或淀粉安慰剂组,每臂58例。
  • 年龄和性别匹配的健康儿童被纳入安慰剂对照组,在研究期间接受淀粉作为安慰剂。
  • 干预/对照持续2个月(8周),数据收集与评估在基线和试验结束时(第8周)进行,安全性监测每两周进行,分析遵循意向性治疗原则。

关键数值与推荐

  • 主要结局为肠道微生物组多样性。
  • 次要结局包括体重别身高/身长Z评分、上臂围、神经发育评估和体质量积累。
  • 采用预先定义的纳入和排除标准,按1:1:1分配比例,每臂招募58名参与者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The anti-inflammatory and antimicrobial benefits of prebiotics may present an affordable and cost-effective strategy for not only the prevention but also treatment of malnutrition. Therefore, the present trial has been designed with the aim to evaluate the role of prebiotics on the gut microbiome of severe acute malnourished (SAM) children. METHODS: The study is designed as a prospective, double-blinded, triple-armed, multi-centered randomized controlled trial, with 6-59 months old uncomplicated SAM children recruited to the experimental group receiving ready-to-use therapeutic food (RUTF) plus prebiotics and the active comparator group receiving RUTF plus starch for 2 months duration (8 weeks). Healthy children with matching age and gender will be recruited to placebo comparator group and will receive starch as a placebo during the study period. A total of 58 participants will be recruited to each arm with 1:1:1 allocation ratio following a pre-defined inclusion and exclusion criteria. The results of the gut microbiome diversity will serve as the primary outcome, while weight-for-height/length z-score, mid-upper-arm circumference, neurodevelopment assessment, and body mass accumulation will serve as the secondary outcome. Data collection and evaluations will be conducted at baseline and at the end of the trial (week 8), while the safety monitoring will be conducted at every second week. For analysis, the principles of intention-to-treat will be followed. CONCLUSIONS: Conclusively, the results of the present trial would provide useful insights and high-quality data for the treatment and management of SAM children by evaluating the effect of RUTF plus prebiotic on the gut microbiome diversity of children, leading to medical evidence for designing the large-scale studies. TRIAL REGISTRATION: The present trial is registered at ClinicalTrials.gov with identifier No: NCT06155474 and registration date 4 December 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Saleem J, Zakar R, Iqbal S, et al. Effects of prebiotics on microbial diversity and abundance in young children with acute malnutrition: study protocol for a multi-centered, double-blinded randomized controlled trial. Trials. 2024. PMID: 39593072. doi:10.1186/s13063-024-08647-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。